Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy
Melanoma is the most fatal skin cancer. In the early stages, it can be safely treated with surgery alone. However, since 2011, there has been an important revolution in the treatment of melanoma with new effective treatments. Targeted therapy and immunotherapy with checkpoint inhibitors have changed...
Main Authors: | Claudia Trojaniello, Jason J. Luke, Paolo A. Ascierto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.670726/full |
Similar Items
-
Editorial of special focus on melanoma immunotherapy
by: Ernesto Rossi
Published: (2022-05-01) -
Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
by: Mayuka Anko, et al.
Published: (2021-05-01) -
Comparative Risks of High-Grade Adverse Events Among FDA-Approved Systemic Therapies in Advanced Melanoma: Systematic Review and Network Meta-Analysis
by: Ya-fang Huang, et al.
Published: (2020-10-01) -
Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma
by: Sena Zeynep Usta, et al.
Published: (2023-12-01) -
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
by: Devayani Machiraju, et al.
Published: (2023-01-01)